Evidence map›Paper›PMID 34272465›Full record

ArticleScientific reports2021

Assessment of quarter billion primary care prescriptions from a nationwide antimicrobial stewardship program.

Mehmet Gönen, Mesil Aksoy, Fatma İşli, Umut Emre Gürpınar, Pınar Göbel, Hakkı Gürsöz, Önder Ergönül

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mehmet GönenDepartment of Industrial Engineering, College of Engineering, Koç University, İstanbul, Turkey. mehmetgonen@ku.edu.tr.
Mesil AksoyTurkish Medicines and Medical Devices Agency (TMMDA) of Ministry of Health, Ankara, Turkey.
Fatma İşliTurkish Medicines and Medical Devices Agency (TMMDA) of Ministry of Health, Ankara, Turkey.
Umut Emre GürpınarTurkish Medicines and Medical Devices Agency (TMMDA) of Ministry of Health, Ankara, Turkey.
Pınar GöbelTurkish Medicines and Medical Devices Agency (TMMDA) of Ministry of Health, Ankara, Turkey.
Hakkı GürsözTurkish Medicines and Medical Devices Agency (TMMDA) of Ministry of Health, Ankara, Turkey.
Önder ErgönülDepartment of Infectious Diseases and Clinical Microbiology, School of Medicine, Koç University, İstanbul, Turkey.
Ministry of Health · TRKoç University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We described the significance of systematic monitoring nationwide antimicrobial stewardship programs (ASPs) in primary care. All the prescriptions given by family physicians were recorded in Prescription Information System established by the Turkish Medicines and Medical Devices Agency of Ministry of Health. We calculated, for each prescription, "antibiotics amount" as number of boxes times number of items per box for medicines that belong to antiinfectives for systemic use (i.e., J01 block in the Anatomical Therapeutic Chemical Classification System). We compared the antibiotics amount before (2015) and after (2016) the extensive training programs for the family physicians. We included 266,389,209 prescriptions from state-operated family healthcare units (FHUs) between January 1, 2015 and December 31, 2016. These prescriptions were given by 26,313 individual family physicians in 22,518 FHUs for 50,713,181 individual patients. At least one antimicrobial was given in 37,024,232 (28.31%) prescriptions in 2015 and 36,154,684 (26.66%) prescriptions in 2016. The most common diagnosis was "acute upper respiratory infections (AURI)" (i.e., J00-J06 block in the 10th revision of the International Statistical Classification of Diseases and Related Health Problems) with 28.05%. The average antibiotics amount over prescriptions with AURI decreased in 79 out of 81 provinces, and overall rate of decrease in average antibiotics amount was 8.33%, where 28 and 53 provinces experienced decreases (range is between 28.63% and -3.05%) above and below this value, respectively. In the most successful province, the highest decrease in average amount of "other beta-lactam antibacterials" per prescription for AURI was 49.63% in January. Computational analyses on a big data set collected from a nationwide healthcare system brought a significant contribution in improving ASPs.

Indexed as

Anti-Bacterial AgentsDrug Utilization ReviewHumansPhysicians, FamilyPractice Patterns, Physicians'Primary Health CareRespiratory Tract InfectionsTurkeyAnti-Bacterial Agents

Identifiers

PMID34272465
PMCPMC8285383
OpenAlexW3179337467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.